CLINICAL_TRIALS
trial_result
· 2018-07-17
Clinical Trial Update: Phase II Study of Tesetaxel in Metastatic Melanoma [Phase 2]
Summary
Phase II study results of Tesetaxel in metastatic melanoma have been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Melanoma, Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-07-17